Dr. Alfred Scheidegger is a Member at Rising Tide Foundation, Partner & Founder at Nextech Invest AG, Chairman at Nextech Holding AG and Chairman at The Genetics Co., Inc.
He is on the Board of Directors at Cleave Biosciences, Inc., Dottikon ES Holding AG, Nextech III GP AG, Nextech Venture Principals Ltd., Dottikon Es Management AG and Dottikon Exclusive Synthesis AG.
Dr. Scheidegger was previously employed as Chief Executive Officer by Swiss Scientific Computing Center and Director-Supervisory Board by Ganymed Pharmaceuticals AG.
He also served on the board at Palyon Medical Corp., TRACON Pharmaceuticals, Inc., Swiss Federal Institute of Technology and ImVisioN Therapeutics AG.
He received his graduate degree from Kyoto University and a doctorate degree from the University of Basel.